Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5351 Target Snapshot

Transcriptional activator protein LuxR · SINGLE PROTEIN · Aliivibrio fischeri

192Compounds
41Assays
3Approved Drugs
136.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P12746. Use UniProt P12746 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P12746 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Transcriptional activator protein LuxR as ChEMBL target CHEMBL5351, mapped to UniProt P12746. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Transcriptional activator protein LuxR
SINGLE PROTEIN · Aliivibrio fischeri
As of 2026-09-14
ChEMBL target ID
CHEMBL5351
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P12746
Transcriptional activator protein LuxR
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Transcriptional activator protein LuxR is the right protein anchor across sources, using UniProt P12746 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTranscriptional activator protein LuxR
UniProt AccessionP12746
Component TypeProtein
Sequence Length250 aa

Transcriptional activator protein LuxR

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Transcriptional activator protein LuxR, mapped to UniProt P12746. Sequence length is 250 aa.

Mapped IDP12746
Review nameTranscriptional activator protein LuxR
OrganismAliivibrio fischeri
Clinical Profile

Clinical Phase Distribution

3
Approved
2
Phase II
Assay Mix

Activity Type Distribution

IC50125.0
EC5011.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1812080 6.89 IC50 130.0 Preclinical
CHEMBL4527540 6.89 IC50 130.0 Preclinical
CHEMBL4517457 6.6 EC50 250.0 Preclinical
CHEMBL1814832 6.51 IC50 310.0 Preclinical
CHEMBL1812089 6.46 IC50 350.0 Preclinical
CHEMBL1814829 6.46 IC50 350.0 Preclinical
CHEMBL405298 6.46 EC50 350.0 Preclinical
CHEMBL8799 6.4 IC50 400.0 Preclinical
CHEMBL1823931 6.35 IC50 450.0 Preclinical
CHEMBL4535946 6.3 EC50 500.0 Preclinical
Distribution

pChEMBL Value Distribution

33
5.0
18
5.5
14
6.0
4
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

41
Total Assays
68
Tested Compounds
2
Assay Types
Functional — 26 assays, 68 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 26 68 5.1
Binding — 15 assays, 49 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 10 45 5.2
assay format 5 4 4.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine